BLOOD CANCER BREAKTHROUGH!
Globe|April 11, 2022
New chemo zaps cancer while leaving healthy cells untouched
BLOOD CANCER BREAKTHROUGH!

REVOLUTIONARY manmade antibodies may help some lymphoma patients substantially cut the risk of a blood cancer relapse while eliminating the need for traditional, damaging chemotherapy, a recent medical trial suggests.

Delivered via an infusion, the medication Polivy — also known as polatuzumab vedotin-piiq uses artificial proteins to carry chemotherapy directly to cancer cells to destroy them while leaving healthy tissue unscathed.

This story is from the April 11, 2022 edition of Globe.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

This story is from the April 11, 2022 edition of Globe.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.